Peptide Initiative

Peptides · Peptide comparison

GHRP-6 (Growth Hormone Releasing Peptide-6) vs Ipamorelin

A synthetic hexapeptide that signals your pituitary to release growth hormone through a unique pathway, with emerging evidence of heart-protective benefits.

A uniquely selective growth hormone booster that tells your pituitary to release more GH without messing with your cortisol or other hormones—making it the 'clean' choice among growth hormone peptides.

  • Growth Hormone
  • Growth Hormone

At a glance

Quick comparison

Dose rangeGHRP-6 (Growth Hormone Releasing Peptide-6)100–100 mcgIpamorelin200–200 mcg
FrequencyGHRP-6 (Growth Hormone Releasing Peptide-6)Multiple times dailyIpamorelinMultiple times daily
AdministrationGHRP-6 (Growth Hormone Releasing Peptide-6)Subcutaneous injectionIpamorelinSubcutaneous injection
Cycle lengthGHRP-6 (Growth Hormone Releasing Peptide-6)8-12 weeksIpamorelin8-12 weeks
Onset speedGHRP-6 (Growth Hormone Releasing Peptide-6)Moderate (1-2 weeks)IpamorelinModerate (1-2 weeks)
Evidence levelGHRP-6 (Growth Hormone Releasing Peptide-6)Limited human trialsIpamorelinModerate human trials (Phase 1-2)

Efficacy

Benefit ratings

Muscle Recovery and Growth

GHRP-6 (Growth Hormone Releasing Peptide-6)85%
IpamorelinNo recorded rating

Cellular Health and Protection

GHRP-6 (Growth Hormone Releasing Peptide-6)72%
IpamorelinNo recorded rating

Appetite and Nutrient Intake

GHRP-6 (Growth Hormone Releasing Peptide-6)88%
IpamorelinNo recorded rating

GH Selectivity

GHRP-6 (Growth Hormone Releasing Peptide-6)No recorded rating
Ipamorelin98%

Recovery Support

GHRP-6 (Growth Hormone Releasing Peptide-6)No recorded rating
Ipamorelin90%

Safety Profile

GHRP-6 (Growth Hormone Releasing Peptide-6)No recorded rating
Ipamorelin92%

Technical data

Compound specifications

GHRP-6 (Growth Hormone Releasing Peptide-6)

Molecular formula
C46H56N12O6
Molecular weight
873.0 g/mol
Half-life
~2.5 hours
Bioavailability
<1% oral, high subcutaneous
CAS number
87616-84-0

Ipamorelin

Molecular formula
C38H49N9O5
Molecular weight
711.85 g/mol
Half-life
2 hours
Bioavailability
High when injected subcutaneously
CAS number
170851-70-4

Protocols

Dosing compared

GHRP-6 (Growth Hormone Releasing Peptide-6)

Subcutaneous

  • ~100 mcg per injection (approx. 1 mcg/kg)1-3 times daily, on an empty stomach · Open-ended in research practiceResearch-practice GH-secretagogue dosing; the ~100 mcg anchor reflects the validated 1 mcg/kg GH-saturating dose, though no isolated subcutaneous human dose-response trial exists [6].

Intravenous

  • 1 mcg/kg bolus (optionally followed by 1 mcg/kg/hr infusion)Single bolus for acute GH testing; infusion studies ran up to ~34 hours · Acute test or infusion studyTrial-established near-maximal GH-releasing intravenous dose in healthy men; pituitary responsiveness maintained over prolonged infusion [6]. Dose-response in men: mean peak GH of 7.6, 16.5, and 68.7 µg/L at 0.1, 0.3, and 1.0 µg/kg respectively [7].

Ipamorelin

Subcutaneous

  • 100 mcg per injection2-3 times daily · 4-8 weeksConservative entry dose; Ipamorelin is a selective GH secretagogue with a ~2 hour half-life, so doses are split through the day [1][2]. Used in research and practice to assess tolerance before titrating up.
  • 200 mcg per injection2-3 times daily · 8-12 weeksMost commonly cited research/practice dose; gives a meaningful pulsatile GH release without raising cortisol or prolactin at standard doses [1][2].
  • 300 mcg per injection3 times daily · 8-12 weeksUpper end of the commonly used range; total daily exposure split across three injections. Used in practice by experienced users [1].

Applications

Best suited for

GHRP-6 (Growth Hormone Releasing Peptide-6)

Athletes and Serious Trainers
If you're hitting the gym hard and want better recovery and muscle growth, GHRP-6 amplifies your body's natural GH response. This is particularly valuable during intense training phases when you want to maximize adaptation and minimize soreness. The appetite stimulation also helps you consume the calories you need to grow.
Those Exploring Novel Peptide Protocols
GHRP-6 offers a unique mechanism through the ghrelin receptor, [9] making it valuable for users who want to explore diverse GH-stimulation pathways. It works distinctly from GHRH-based approaches and pairs well with other GH secretagogues for synergistic effects [7].
Longevity and Metabolic Health Enthusiasts
Growth hormone plays roles in metabolic health, body composition, and potentially aging markers. GHRP-6's emerging research on cellular protection and antioxidant activation [1] makes it interesting for those interested in broader health optimization beyond just muscle growth.

Ipamorelin

Clean GH Boost Seekers
If you want the benefits of increased growth hormone without spiking cortisol or other stress hormones, Ipamorelin is uniquely selective. Unlike GHRP-2 or GHRP-6, it won't raise your cortisol levels even at doses 200 times higher than needed for GH release.
Recovery-Focused Athletes
Ipamorelin shines for athletes who want better recovery between training sessions. The GH boost helps repair muscle tissue faster, and since it doesn't mess with other hormones, you can use it consistently without the rollercoaster effects.
Anti-Aging Enthusiasts
Growth hormone naturally declines as we age, contributing to muscle loss, fat gain, and reduced vitality. Ipamorelin offers a gentle way to restore more youthful GH levels without the risks of actual HGH therapy.
Those Recovering from Steroid Use
Research shows Ipamorelin can help counteract the muscle and bone-weakening effects of glucocorticoid medications. If you've been on steroids for medical reasons, this peptide may help you rebuild what you've lost.

Safety profile

Side effects

GHRP-6 (Growth Hormone Releasing Peptide-6)

Common

  • Increased Appetite
  • Mild Joint or Muscle Discomfort
  • Water Retention or Mild Swelling

Uncommon

  • Sleep Disturbances
  • Mild Dizziness or Lightheadedness

Serious

  • Allergic Reaction

Ipamorelin

Common

  • Mild headache
  • Injection site reactions
  • Water retention
  • Increased appetite

Uncommon

  • Tingling in hands or feet
  • Joint stiffness

Serious

  • Allergic reaction

Research status

Safety & evidence

GHRP-6 (Growth Hormone Releasing Peptide-6)

Evidence level
Limited human trials
FDA status
Research compound
Safety overview
GHRP-6 has a relatively long research history dating back to 1981, with human studies demonstrating its ability to stimulate GH release. [3] The good news is that animal safety studies show excellent tolerability at high doses, [2] and the side effects reported are generally mild and reversible. However, it's not FDA-approved, so use is based on research evidence rather than pharmaceutical oversight. Always purchase from reputable sources and consider medical consultation, especially if you have existing health conditions.

Contraindications

  • Known allergy or sensitivity to any component of the peptide
  • Active cancer or history of cancer without medical clearance
  • Severe cardiovascular disease or uncontrolled hypertension
  • Acute critical illness or sepsis

Ipamorelin

Evidence level
Moderate human trials (Phase 1-2)
FDA status
Research compound
Safety overview
Ipamorelin's main selling point is that it raises growth hormone without raising cortisol or ACTH — two stress hormones that similar peptides do raise. That was shown in pigs, and it held even at doses more than 200 times higher than the amount needed to raise growth hormone [1]. It has not been checked in people. The two published human studies measured ipamorelin and growth hormone only; neither one assayed cortisol, ACTH or prolactin [2][3]. Most of what we know about safety in people comes from a single trial in patients recovering from bowel surgery. 114 people took part: 56 got ipamorelin through an IV for up to seven days, and 58 got a placebo. Most side effects were mild to moderate, and were the kind you would expect after surgery [3]. Serious problems happened at about the same rate in both groups — roughly 1 in 6 either way (17.9% on ipamorelin, 15.5% on placebo). But three things were more common on ipamorelin: low potassium in about 1 in 8 people versus about 1 in 30 on placebo (12.5% vs 3.4%), trouble sleeping in about 1 in 9 versus about 1 in 19 (10.7% vs 5.2%), and high blood sugar at discharge in about 1 in 7 versus about 1 in 12 (14.3% vs 8.6%) [6]. Two people taking ipamorelin died. Both had colon cancer surgery, and in both cases the surgical join in the bowel leaked afterward. Nobody on the placebo died. The FDA says it is unclear whether those deaths had anything to do with ipamorelin — but it pointed to them, along with the potassium and blood sugar differences, when it recommended in October 2024 against letting pharmacies compound ipamorelin [6].

Contraindications

  • Active cancer or history of cancer
  • Pregnancy or breastfeeding
  • Pituitary disorders or tumors
  • Known allergy to peptide components
  • Children and adolescents (growth plates still open)

Decision guide

Which is right for you?

GHRP-6 (Growth Hormone Releasing Peptide-6)

Choose GHRP-6 (Growth Hormone Releasing Peptide-6) if…

  • Building lean muscle mass and improving body composition
  • Recovery from intense training programs and athletic performance
  • Supporting overall metabolic health and longevity markers
  • Exploring novel GH-stimulation pathways for those who respond well to peptide protocols

Ipamorelin

Choose Ipamorelin if…

  • Muscle recovery and growth
  • Anti-aging and vitality
  • Body composition improvement
  • Sleep quality enhancement